The prepared EGF-QDs exhibited optimal pharmacokinetics and superior docking ability to EGFR, which allowed quantifiable imaging of EGFR expression in human colorectal cancer xenografts in mice (Diagaradjane et al., 2008). This evidence concerns the gene EGFR and colorectal cancer.